China injects Covid-19 Vaccines to “hundreds of thousands”
Published: 02:31 PM, 12 September 2020
A Chinese pharmaceutical firm has injected hundreds of thousands with one of two experimental vaccines for COVID-19, The Wall Street Journal (WSJ) reported on Friday.
China National Biotec Group (CNBG), a subsidiary of state-owned Sinopharm, has given the unproven inoculations under an emergency scheme approved by the China government in July, the Journal reported.
Earlier on Monday, Zhong Song - the company’s chief legal officer - told reporters that the two vaccine candidates developed by CNBG can also protect people from the coronavirus for as long as three years.
In a separate report on Friday by Bloomberg, CNBG and other Chinese vaccine developers emphasized the safety of their medication.
The latest report follows others in which a separate Chinese company, Sinovac Biotech, reported at a trade fair in Beijing last week that it, too, had injected between 2,000 and 3,000 of its employees and family members with its experimental vaccine.
According to the Bloomberg report, the potential vaccines are two of about 35 candidates being developed around the world and are still undergoing Phase 3 clinical trials.
In August, Russia announced it had successfully developed its vaccine.
The Chinese government gave the OK for its military members to receive an experimental vaccine developed by CanSino Biologics in June, and then authorized broader use for medical workers a month later.
CNBG’s Zhou Song said via the company’s social media account that no one who received the inoculation had become infected with the SARS-CoV-2 virus that causes the respiratory affliction COVID-19 nor experienced any obvious adverse reactions. Wall Street Journal, Daily Mail, Newsmax